News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cytox Release: Role Of mTOR Pathway As A Marker Of Risk In Alzheimer's Disease To Be Presented At AAIC 2014



7/14/2014 10:25:00 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cytox, a leading developer of assays for risk assessment and prediction of dementia, announced the timing of a presentation discussing the development of a novel proprietary blood-based assay for the assessment of risk of cognitive decline.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Cytox
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES